We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+39.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$195M
AUM Growth
+$32.2M
Cap. Flow
-$25.8M
Cap. Flow %
-13.2%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$21.5M
2
IL
IntraLinks Holdings Inc.
IL
+$3.4M
3
VRNM
VERENIUM CORP COM STK (US)
VRNM
+$861K

Sector Composition

Rank Sector Weight
1 Technology 47.06%
2 Healthcare 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IL
1
DELISTED
IntraLinks Holdings Inc.
IL
$91.8M 47.06%
7,584,296
-323,716
-4% -$3.4M
ANAC
2
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$68.3M 34.97%
4,067,892
-1,553,531
-28% -$21.5M
RLOC
3
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$35M 17.95%
2,756,966
– –
GNVC
4
DELISTED
GenVec, Inc.
GNVC
$42K 0.02%
1,804
– –
VRNM
5
DELISTED
VERENIUM CORP COM STK (US)
VRNM
– –
-216,902
Closed -$861K

Similar funds

LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

Rho Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Rho Capital Partners held 5 positions worth $195M, up 20% from $163M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners withdrew a net $25.8M in Q4 2013, closing 1 position and reducing 2 holdings. Its most notable exit was VERENIUM CORP COM STK (US), an estimated $861K position sold in full.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Healthcare.

  • Rho Capital Partners's biggest Q4 2013 reduction was ANACOR PHARMACEUTICALS INC COM, cutting an estimated $21.5M.
  • Rho Capital Partners fully exited VERENIUM CORP COM STK (US) in Q4 2013, selling an estimated $861K.
  • Rho Capital Partners's ten largest holdings make up 100% of its $195M portfolio in Q4 2013.
  • Rho Capital Partners opened 0 new positions and closed 1 in Q4 2013.
  • Rho Capital Partners's portfolio value rose 20% quarter-over-quarter to $195M.

Based on Rho Capital Partners's 13F filing for Q4 2013, filed 24 Jan 2014.